Collecting Bio Information against COVID-19
with Pse-in-One Software
Volume 5 - Issue 3
Cemil Koyunoğlu*
-
Author Information
Open or Close
- Department of Energy Systems Engineering, 77200-Center Campus Yalova, Turkey
*Corresponding author:
Cemil Koyunoğlu, Department of Energy Systems Engineering, 77200-Center Campus Yalova, Turkey
Received: July 01, 2020; Published: July 14, 2020
DOI: 10.32474/OAJESS.2020.05.000215
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
A better understanding of the genetic codes of the Covid-19 virus, especially in vaccination studies, reaching 328 million cases
worldwide and still being 40% of community immunity, requires the normalization of vaccine and drug treatments by 60% of
community immunity and standardization of the outbreak. It is going to continue up to 40 months. The focus of our study, which
we will describe the Pse-in-One software, is to ensure that the correct vaccine is produced in vaccine studies. In the review of Liu et
al. published in a nucleic acid science journal in 2015 and Nature science journal in 2017, how this program became functional is
summarized in this study. I hope this article helps scientists in vaccine and drug development. I wish you good days.
Abstract|
Introduction|
Introduction to Pse-in-One 2.0|
Conclusion|
References|